about
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal P...
Read More
1.31
-0.07
(-5.07%)
58,529
XNAS Volume
XNAS 15 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioVie Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..